Table 4.
Case | Type of Infection | Concomitant BSI | Therapy Before C/T | Dose of C/T for the Present Infection | Concomitant Isolates | Additional Information | Reason for Clinical Failure |
---|---|---|---|---|---|---|---|
1 | HAP | Yes | Cefepime | Off-label dosage | No | Septic shock, CRRT | Died |
2 | HAP | Yes | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | Acinetobacter baumannii | Septic shock | Died |
3 | HAP | Yes | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | Acinetobacter baumannii | Septic shock, CRRT | Lack of clinical response |
4 | HAP | Yes | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | Septic shock | Died |
5 | HAP | Yes | Piperacillin/tazobactam | Off-label dosage | No | Septic shock | Lack of clinical response |
6 | HAP | Yes | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | CRRT | Lack of clinical response |
7 | VAP | Yes | Piperacillin/tazobactam | Off-label dosage | No | Septic shock | Died |
8 | VAP | Yes | Piperacillin/tazobactam | Off-label dosage | No | Septic shock | Lack of clinical response |
9 | VAP | Yes | Meropenem | Off-label dosage | No | CRRT | Lack of clinical response |
10 | VAP | Yes | Meropenem | Standard dosage (or adjusted according to creatinine clearance) | No | Septic shock | Died |
11 | VAP | No | Meropenem | Standard dosage (or adjusted according to creatinine clearance) | Acinetobacter baumannii | Septic shock, CRRT | Died |
12 | VAP | No | Meropenem | Standard dosage (or adjusted according to creatinine clearance) | No | Septic shock | Died |
13 | VAP | No | Cefepime | Standard dosage (or adjusted according to creatinine clearance) | No | Septic shock | Died |
14 | cUTI | No | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock, CRRT | Died |
15 | cUTI | No | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock, CRRT | Died |
16 | cUTI | No | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock | Lack of clinical response |
17 | cIAI | Yes | Ceftriaxone+metronidazole | Augmented renal clearance | Acinetobacter baumannii | Inadequate source control of infection | Lack of clinical response |
18 | cIAI | Yes | Levofloxacin+metronidazole | Standard dosage (or adjusted according to creatinine clearance) | Enterococcus faecium vancomycin-resistant | Inadequate source control of infection, inadequate antimicrobial therapy | Lack of clinical response |
19 | cIAI | No | Piperacillin/tazobactam | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock | Lack of clinical response |
20 | cIAI | No | Ceftriaxone+metronidazole | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock, CRRT | Died |
21 | cIAI | No | Ceftriaxone+metronidazole | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, CRRT | Died |
22 | cIAI | No | Cefepime+metronidazole | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock, CRRT | Died |
23 | Bone infection | No | Cefepime+levofloxacin | Standard dosage (or adjusted according to creatinine clearance) | No | Inadequate source control of infection, septic shock | Lack of clinical response |
24 | Primary bacteremia | - | Cefepime | Standard dosage (or adjusted according to creatinine clearance) | MRSA | Septic shock | Died |
25 | Primary bacteremia | - | Ceftriaxone | Augmented renal clearance | MRSA | Septic shock | Died |
Abbreviations: CRRT, continuous renal replacement therapy; HAP, hospital-acquired pneumonia; IAI, intra-abdominal infection; MRSA, methicillin-resistant Staphylococcus aureus; UTI, urinary tract infection; VAP, ventilator-associated pneumonia.